Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-11-028251)

Filing Details

Accession Number:: 0001181431-11-028251
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-05-09 17:20:45
Reporting Period:: 2011-05-05

Filing Date:: 2011-05-09
Accepted Time:: 2011-05-09 17:20:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1001233	Sangamo Biosciences Inc	SGMO	Biological Products, (No Disgnostic Substances) (2836)	680359556

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1324506	G David Ichikawa	C/O Sangamo Biosciences Inc., Ste A-100 Point Richmond Tech Cntr, 501 Canal Blvd Richmond CA 94804	Senior Vp, Bus. Dev.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-05-05	4,000	$5.19	4,000	No	4	M	Direct
Common Stock	Disposition	2011-05-05	4,000	$6.74	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2011-05-05	4,000	$0.00	4,000	$5.19

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
65,068		2014-12-19	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on or about March 11, 2011.
Options vest as follows: (i) 25% of the option shares on December 20, 2005, and (ii) the remaining shares vest in a series of successive monthly installments over the remaining 36 months thereafter.